Tepkinly
Imported from official source
Tepkinly Active substance Epcoritamab Holder AbbVie Belgium SA/NV Status Running Indication Epcoritamab in combination with lenalidomide and rituximab (R²) for the treatment of relapsed or refractory Follicular Lymphoma (FL), previously treated with at least 1 line of systemic chemoimmunotherapy (2L+). …
This version
- Version
- 1 of 1
- Recorded
- October 03, 2026 20:37
- Change
- Initial
- Content hash
7ce7e156d24752d7cf516bdac883e57f- All versions
- Revision history